Skip to Content

What is the most important blood test for multiple myeloma?

The most important blood test for multiple myeloma is a complete blood count (CBC). This test looks for abnormal amounts of different types of blood cells, such as red blood cells (erythrocytes), white blood cells (leukocytes), and platelets (thrombocytes).

Abnormal amounts of these cells can indicate an existing myeloma. In addition to the CBC, other blood tests that may be used to diagnose and evaluate the extent of multiple myeloma include: serum protein electrophoresis (which helps to identify myeloma protein and any other abnormal proteins), immunofixation (which helps to identify abnormal proteins), kidney function tests (which look for the presence of myeloma kidney disease), and liver function tests (which look for the presence of myeloma liver disease).

The presence of bone marrow abnormalities can also be evaluated by bone marrow biopsy. This can help to stage the cancer and determine if treatment is necessary.

What blood tests indicate multiple myeloma?

A typical diagnosis of multiple myeloma starts with a patient’s medical history being taken and a physical examination. If the physician suspects that the patient has multiple myeloma, they may order one or more of the following blood tests to confirm the diagnosis:

Complete Blood Count (CBC): A CBC test can help confirm the presence of multiple myeloma by measuring the number of red and white blood cells and platelets. If the levels of red blood cells, white blood cells, and platelets are abnormally low, it can point to the presence of multiple myeloma.

Blood Protein (Serum Proteins): Serum proteins are chemicals found in the blood that can be used to assist with diagnosing multiple myeloma. Specifically, a blood protein test can measure levels of immunoglobulins, which are proteins that are produced by plasma cells.

Higher than normal immunoglobulin levels can indicate multiple myeloma has developed.

Serum Free Light Chain (SFLC) Test: The SFLC test measures the ratio of two types of abnormal light chain proteins produced by abnormal cancerous plasma cells in the body in cases of multiple myeloma.

These proteins are called kappa and lambda. An abnormal ratio of these proteins is typically associated with multiple myeloma.

Beta-2-Microglobulin Test: This test measures the level of beta-2-microglobulin (B2M) in the blood, which is a protein produced in quantities higher than normal when multiple myeloma is present.

Cytogenetic Test: A cytogenetic test looks for any abnormal changes in a person’s genetic material. This type of test can be used for diagnosing multiple myeloma by identifying changes in chromosomal material, which is an indication that can signal the presence of multiple myeloma.

Does multiple myeloma show up in routine blood tests?

No, multiple myeloma does not typically show up in routine blood tests. Routine blood tests only detect changes in hemoglobin levels and minor red and white blood cell abnormalities. Multiple myeloma is a type of cancer that affects the plasma cells in the bone marrow, resulting in abnormal proteins in the blood, including an increased amount of monoclonal immunoglobulins (M proteins).

Although there are other tests available that can detect abnormal proteins, such as a serum protein electrophoresis (SPEP) test, multiple myeloma is often not picked up until symptoms become evident or if a person has some type of routine medical screening, such as a bone marrow biopsy.

If initial routine blood testing signals a problem, a doctor may order additional tests to determine if multiple myeloma is present.

How does myeloma show up in blood work?

Myeloma may show up in blood work as an increase in certain proteins, called M proteins. These are abnormal immunoglobulins produced by myeloma cells that can be detected in the blood. An increase in the levels of M proteins is one of the primary ways to detect myeloma.

Additionally, blood tests may reveal an increased number of red blood cells as well as an increased sedimentation rate, which is a measure of the speed at which red blood cells settle to the bottom of a test tube.

Low levels of normal immunoglobulins and altered levels of other proteins may also be observed in the blood work of a person with myeloma. Finally, a decrease in white blood cells and platelets can be seen in the blood work of someone with myeloma.

Is WBC high or low with multiple myeloma?

A person with multiple myeloma typically has a high white blood cell (WBC) count. The presence of multiple myeloma typically results in an overproduction of abnormal plasma cells, which are a type of white blood cell.

This overproduction leads to an increased number of these cells, known as a raised WBC count. This is the reason why a person with multiple myeloma usually has high WBC levels. Patients with multiple myeloma may experience other symptoms, such as anemia, fatigue, increased risk of infection, and bone pain.

It is important that multiple myeloma is diagnosed as early as possible in order to treat it as effectively as possible.

How is multiple myeloma first detected?

Multiple myeloma is typically first detected by routine blood and urine tests performed as part of a general health checkup. These tests may detect high levels of certain proteins called M-spikes associated with multiple myeloma.

Additionally, a person’s doctor may also order a bone marrow biopsy if protean or white blood cell abnormalities are seen in a patient’s blood tests. A bone marrow biopsy involves taking a small sample of bone marrow and lymph nodes from a person’s hip or sternum and examining it under a microscope to detect changes in cells associated with the disease.

Additionally, imaging tests, such as X-rays of the bones or MRI scans, may also be ordered to detect physical changes associated with multiple myeloma.

Which 3 laboratory markers are involved in the staging and prognosis of multiple myeloma?

The three laboratory markers most commonly used in the staging and prognosis of multiple myeloma are the serum albumin level, beta-2 microglobulin level, and the M-component (also known as the M-spike).

The serum albumin level reflects the proteins in the blood and helps indicate the severity of systemic inflammation. The beta-2 microglobulin level can help determine how much the disease has spread, and the M-component is produced by the clonal plasma cells and is used to measure disease activity.

It is important to note that while these laboratory markers are helpful in the staging and prognosis of multiple myeloma, they are not the only diagnostic criteria used. Other laboratory tests, such as the CBC, serum creatinine, and urine analysis, can help provide more detailed information about the patient’s medical condition.

Additionally, imaging tests such as x-rays and computerized tomography (CT) scans can help diagnose and stage multiple myeloma as well.

Is PET scan better than MRI for multiple myeloma?

The answer to this question is that it depends on the individual case. PET scans and MRI scans both have advantages and disadvantages for imaging multiple myeloma. Generally, PET scans are more specific for detecting the spread of tumors and the presence of metabolic activity (changes linked to the spread of cancer).

MRI scans can provide more detailed images of soft tissue and bone, such as tumors and fractures. PET scans may be better for monitoring treatment progress, while MRI scans may be preferable for getting a better sense of the tumor’s exact location or size.

Ultimately, the choice of which scan to use should be based on the individual needs of the patient. The doctor will determine which scan is more suitable in a given situation.

Can myeloma be missed in a blood test?

Yes, it is possible for myeloma to be missed in a blood test. Myeloma is a type of cancer that forms in the plasma cells of your bone marrow. Since these cells are not normally found in the blood stream, the presence of myeloma cells may be difficult to detect.

Additionally, detecting myeloma in a blood test would require a very sensitive assay and could be easily missed.

In order to diagnose myeloma, doctors typically perform a bone marrow biopsy or a bone survey. During a bone marrow biopsy, a small tissue sample is removed from the bone marrow and examined for abnormal cells.

A bone survey involves taking a series of x-rays to look for any abnormal bone structures that may be caused by a myeloma tumor.

If a doctor suspects the presence of myeloma, they may order additional blood tests, such as a complete blood count, chemistry panel, immunofixation, and free light chain assay, to help diagnose the condition.

Ultimately, additional testing is needed to definitively diagnose myeloma.

Can you have myeloma with normal blood work?

Yes, it is possible to have myeloma with normal blood work. This condition, also known as smoldering multiple myeloma (SMM), is a condition in which cancerous plasma cells accumulate in the bone marrow, but there are no typical myeloma-related symptoms such as bone pain or anemia.

However, underlying changes in blood work, such as small increases in M protein and IgA (immunoglobulin A) can be detected, and may indicate that a person has SMM. To diagnose SMM, doctors typically order a blood test, an X-ray or a bone marrow biopsy to confirm the presence of abnormal plasma cells.

While SMM may not always progress to active multiple myeloma, regular follow-up with a doctor is important in order to detect any changes in blood work or other symptoms, and make sure the condition is being monitored.

Would a CBC show multiple myeloma?

A complete blood count (CBC) can be useful in helping to diagnose multiple myeloma. These signs may include a low red blood cell count, anemia due to a decrease in the production of red blood cells, low platelet count, increased white blood cell count and/or an increase in the immature forms of white blood cells (immature granulocytes and monocytes).

Other laboratory tests may also be recommended such as serum protein electrophoresis (SPEP) or urine protein electrophoresis (UPEP), which can detect the presence of abnormal proteins. Additionally, a bone marrow sample may be taken for biopsy in more advanced stages of the disease to determine if abnormal cells are present.

Can multiple myeloma be missed?

Yes, multiple myeloma can be missed. While it is one of the more common bone marrow cancer, it can still be overlooked or not suspected as the cause of a person’s symptoms. Multiple myeloma is often diagnosed after somebody presents with signs or symptoms suggestive of it, such as bone pain, anemia, kidney damage, infection, or bone fractures.

It can also be diagnosed after a blood or urine test reveal the presence of high levels of certain proteins and other cancer markers.

In some cases, however, multiple myeloma can be difficult to diagnose. Even if tests for protein levels are abnormal, the cause may not be clear, and further testing may be required. Additionally, in some cases, the signs and symptoms of multiple myeloma can be very subtle or mild, making it easy to miss or overlook.

Anyone experiencing persistent symptoms such as persistent fatigue, bone pain, or frequent infections should consult with a medical professional, even if they have already received a diagnosis of another condition.

What conditions are mistaken for myeloma?

Including other types of cancer, such as lymphoma or leukemia, anemia, Paget’s disease, Alzheimer’s disease, multiple sclerosis, Waldenström macroglobulinemia, amyloidosis, rheumatoid arthritis, and kidney disease.

Myeloma is a rare form of cancer that develops in the blood’s plasma cells, and its symptoms can be similar to those of many other illnesses and conditions. Anemia, for example, is a condition in which red blood cell production is decreased, causing fatigue, pale skin, cold hands and feet, and shortness of breath.

Paget’s disease is a condition in which a person’s bones become abnormally thick and brittle due to the abnormal wearing away of bone tissue. Alzheimer’s disease is a type of dementia that affects memory, thinking, and behavior.

Multiple sclerosis is an autoimmune disorder that affects the central nervous system and can cause muscle spasms, numbness, and problems with vision, speech, and coordination.

Waldenström macroglobulinemia is a type of slow-growing non-Hodgkin’s lymphoma that affects certain white blood cells, or macroglobulins. Amyloidosis is a disease in which harmful proteins called amyloids build up in the tissue and organs, causing organ damage and other symptoms.

Rheumatoid arthritis is an autoimmune disorder characterized by inflammation and is accompanied by joint pain, stiffness, and swelling. Kidney disease occurs when the kidneys are no longer able to filter toxins and waste products from the blood properly.

It is important to discuss any symptoms and other health conditions with your doctor, in order to determine the best course of treatment. If your doctor suspects that you may have myeloma, they will often order tests to confirm the diagnosis.

These tests may include a bone marrow biopsy, a complete blood count, imaging tests, and other tests to check for levels of the proteins produced by cancerous plasma cells.

When should I suspect myeloma?

If you have signs or symptoms that suggest you may have myeloma, you should contact your healthcare provider right away. Some common signs and symptoms that may indicate myeloma include persistent fatigue and weakness, frequent infections, easily broken bones, weight loss, night sweats, itching, and appetite loss.

While these symptoms can be indicative of other conditions, if you experience any combination of them, they should be checked out by a healthcare provider as soon as possible. In addition, if you have a family history of myeloma or know that you are at an increased risk, it is important to be aware of the signs and symptoms and report any that you experience even if you are unsure.

While these symptoms can be caused by other conditions, it is important to speak with a healthcare provider for proper diagnosis and treatment.